Page 25 - சூரியன் மருந்து தொழில்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

May 17, 2021 Says MRP of medical devices cannot be increased more than 10% in a year The National Pharmaceutical Pricing Authority of India (NPPA) has fixed the price of two Covid-19 drugs, Budesonide and Dexamethasone, at ₹40.17 per tablet of 9 mg and ₹3.6 per tablet of 6 mg, respectively, exclusive of goods and services tax (GST). According to an order from the NPPA, while the price cap of Budesonide is for manufacturers Sun Pharmaceutical Industries Ltd and Sun Pharma Laboratories Ltd, the price of Dexamethasone has been fixed for Cadila Healthcare Ltd and Zydus Healthcare Ltd. MRP of devices Meanwhile, the NPPA has also ordered that the maximum retail price (MRP) of medical devices such as pulse oximeter and oxygen concentrators cannot be increased by more than 10 per cent in a year. It has asked all manufacturers and importers of pulse oximeter and oxygen concentrators to submit the MRP details in the prescribed format latest by May 22.

Zydus healthcare ltdSun pharma laboratories ltdSun pharmaceutical industries ltdCadila healthcare ltdCentral drugs standard control organisationNational pharmaceutical pricing authority of indiaNational pharmaceutical pricing authorityZydus healthcareEssential commoditiesCovid drugsPrices of dexamethasonePrice of budesonideNppa on covid drug priceஜய்துச் சுகாதாரம் லிமிடெட்சூரியன் பார்மா ஆய்வகங்கள் லிமிடெட்சூரியன் மருந்து தொழில்கள் லிமிடெட்